TAT-003

N/A

Report date: 2025/01/15 11:21:49

Base Information

Drug NameTAT-003
Drug Alias NameTAT003
ClassificationBiologics
Mechanisms of ActionAnti-Programmed death-ligand 1Interleukin-2 modulatorsToll like receptor 9 modulators
TargetsProgrammed death-ligand 1Interleukin-2Toll like receptor 9
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTATUM Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesTATUM Bioscience Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A